Beta
Company data is growing.
← All companies
/
Top lists
/
AbbVie
AbbVie
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
25 638
28 216
32 753
33 266
45 804
56 197
58 054
54 318
56 334
61 160
Operating profit (EBIT)
9 384
9 592
6 383
12 983
11 363
17 924
18 117
12 757
9 137
15 075
Net income attributable to shareholders
5 953
5 309
5 687
7 882
4 616
11 542
11 836
4 863
4 278
4 226
EBIT margin
36,6%
34,0%
19,5%
39,0%
24,8%
31,9%
31,2%
23,5%
16,2%
24,7%
Gross margin
77,3%
75,1%
76,4%
77,6%
66,4%
69,0%
70,0%
62,4%
70,0%
70,2%
Operating cash flow
7 041
9 960
13 427
13 324
17 588
22 777
24 943
22 839
18 806
19 030
Free cash flow
6 562
9 431
12 789
12 772
16 790
21 990
24 248
22 062
17 832
17 816
Cash
5 100
9 303
7 289
39 924
8 449
9 746
9 201
12 814
5 524
5 229
Interest-bearing debt
—
—
—
75 445
84 982
—
63 129
67 457
66 841
—
0
20 000
40 000
60 000
80 000
0,0%
10,0%
20,0%
30,0%
40,0%
50,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
25 638
28 216
32 753
33 266
45 804
56 197
58 054
54 318
56 334
61 160
9 384
9 592
6 383
12 983
11 363
17 924
18 117
12 757
9 137
15 075